
Group: Randox

Catalog excerpts

SMALL DENSE LDL CHOLESTEROL (SDLDL-C) SIZE MATTERS: THE TRUE WEIGHT OF RISK IN LIPID PROFILING
Open the catalog to page 1
Background Cardiovascular disease (CVD) is recognised as a leading cause of death, with approximately 17.7million deaths per year, an estimated 31% of all deaths worldwide. Furthermore, 80% of all CVD deaths are due to heart attacks and strokes10. There is a global commitment to reduce the probability of premature CVD deaths by 25% by 2025; a target set by the United Nations member states9. Globally, the mortality rate for CVD has dramatically declined over the past 20 years, however, in low and middle-income regions, the number of lives lost to CVD is increasing9. The global distribution...
Open the catalog to page 2
Table 1: Size and density comparison between lbLDL-C and sdLDL-C Risk Assessment As sdLDL-C is particularly atherogenic, a person with elevated sdLDL-C levels has a 3-fold increased risk of myocardial infarction (MI).2 sdLDL-C measurement therefore provides a more comprehensive understanding of cardiovascular disease (CVD) risk compared to traditional LDL-C tests. These factors provide evidence for sdLDL as a valuable screening tool for predicting future cardiovascular events and in the secondary prevention of subtle coronary artery disease (CAD). Figure 2: Atherogenic mechanism of sdLDL-C5...
Open the catalog to page 3
sdLDL-C Measurement vs Calculation A recent paper investigated if sdLDL-C provided an independent atherosclerotic cardiovascular disease (ASCVD) risk factor in various subgroups and set out to determine if there were significant differences in sdLDL-C concentration when measured directly or determined through a calculation method7. Findings showed that men were at an increased risk of ASCVD, CHD and stroke when compared to women. Unsurprisingly, they also reported that risk of ASCVD, CHD and stroke increased with age7. A significant difference between direct and calculated sdLDL-C...
Open the catalog to page 4
Methods of Detection sdLDL-C can be easily implemented in the routine biochemistry lab using the Randox IT assay. The only direct automated sdLDL-C kit on the market, the Randox sdLDL-C test is a direct method for the quantitative determinationof sdLDL-C using automated chemistry analysers capable of accommodating tworeagent assays. The assay consists of two steps and is based on the use of well-characterised surfactants and enzymes that selectively react with certain groups of lipoproteins. Figure 3: The Gensini score (Non-diabetic Stable CHD)2 The Gensini score (Non-diabetic stable CHD)...
Open the catalog to page 5
Figure 4: Correlation of Ultracentrifugation & Clearance methods6 Clearance (mg/dL) Figure three – Correlation between the Ultracentrifugation and Denka Seiken Methods (7) Ultracentrifugation (mg/dl) The Randox automated sdLDL-C assay correlates well with the gold standard ultracentrifugation method. Ordering Details Description Controls and Calibrators for Direct sdLDL-C Kit Description sdLDL-C Calibrator sdLDL-C Control Level 1 sdLDL-C Control Level 2 sdLDL-C Control Level 3
Open the catalog to page 6
Conclusions CVD is a leading cause of death around the world. Although mortality rates associated with CVD have been in decline for the past 20 years, this is not evident in low to middle income countries and many are living with severe side effects related to these diseases. Therefore, it is essential to review the traditional methods of lipid quantification to enable clinician’s to gain a more comprehensive view of CVD risk, allowing more appropriate preventative measures to be taken. The current lipid panel consists of testing: • Total Cholesterol • HDL Cholesterol • LDL Cholesterol •...
Open the catalog to page 7
Copyright © 2019 Randox Laboratories Ltd. All rights Reserved. VAT number: GB 151682708. Product availability may vary from country to country. Some products may be for Research Use Only. For more information on product application and availability, please contact your local Randox Representative
Open the catalog to page 8All Randox Laboratories catalogs and technical brochures
-
LT735 Vivalytic Overview
32 Pages
-
Acusera New Controls
8 Pages
-
Acusera 24.7
24 Pages
-
Acusera Third Party Controls
108 Pages
-
Acusera SMART Controls
12 Pages
-
Company Overview
40 Pages
-
Reagents Brochure
64 Pages
-
RX SERIES ANALYSER OVERVIEW
24 Pages
-
RX modena
20 Pages
-
RX misano
20 Pages
-
RX Daytona Plus
20 Pages
-
Rx Imola
20 Pages
-
RX Monaco
20 Pages
-
2024 Product List
64 Pages
-
LT107 Evidence Investigator
32 Pages
-
VeraSTAT-V
16 Pages
-
LT033 RIQAS Explained
64 Pages
-
VERASTAT
16 Pages
-
Endocrine Array
4 Pages
-
Cerebral Arrays
4 Pages
-
Thyroid Arrays
4 Pages
-
Respiratory Multiplex Array
8 Pages
-
LT253 Molecular Diagnostics
20 Pages
-
LT367 FH Array Brochure
4 Pages
-
The role of EQA in QC
8 Pages
-
Basic QC Stastics
8 Pages
-
Commutability Guide
4 Pages
-
How to measure uncertainty
8 Pages
-
ISO 15189 Educational Guide
8 Pages
-
Troubleshooting QC Errors
8 Pages
-
Qnostics
52 Pages
-
Adiponectin LT519
28 Pages
-
Specific Proteins
40 Pages
-
Linearity sets
12 Pages
-
Antioxidants
16 Pages
-
Cardiology & Lipid Testing
28 Pages
-
Diabetes Portfolio
28 Pages
-
Total Bile Acids
4 Pages
-
VIVALYTIC
30 Pages
-
RANDOX DISCOVERY
36 Pages
-
HbA1c
2 Pages
-
Preparing QC
1 Pages
-
Point of Care Testing
12 Pages
-
LT394 Using QC Multirules
1 Pages
-
Guide to running QC
1 Pages
-
Tumour Marker Arrays
4 Pages
-
Which QC is the Right QC
8 Pages
-
How often is right for QC
6 Pages
-
Cardiac Risk Multiplex Array
4 Pages
-
LT241 Metabolic Array MAY15
8 Pages
-
KRAS / BRAF / PIK3CA Array*
4 Pages
-
Custom Arrays for Biochip
12 Pages
-
LT169 Cardiac Array
4 Pages
Archived catalogs
-
ACUSERA
108 Pages
-
Evidence Evolution
28 Pages
-
Evidence
16 Pages
-
Metabolic Syndrome Arrays
8 Pages
-
STI Multiplex Array
8 Pages
-
Molecular Testing
16 Pages
-
Evidence Investigator
20 Pages
-
Fertility Array
4 Pages
-
Rx Daytona
16 Pages
-
Evidence Investigator
16 Pages
-
Evidence
16 Pages